News

  • We are delighted to announce that our recent study, delving into the non-canonical pathway for Rb inactivation and its impact on cell proliferation, has been accepted for publication in Nature Communications. Heartfelt congratulations to Mimi Zhang and Sungsoo Kim for their outstanding contributions to this achievement (2023).
  • Jessica Armand received Trainee Associate Member Travel Award (2023). Congratulations to Jessica!
  • Our recent study exploring the mechanism of CDK4/6 inhibitor resistance in breast cancer has been accepted for publication in Cell Reports. Congratulations to Sungsoo Kim and all co-authors (2023).
  • Yang Lab awarded the V Scholar grant by the V foundation (2023).
  • Yang Lab awarded an R01 grant by the National Institute of General Medical Sciences (NIGMS) (2023).
  • Excited to share our new work describing the role of RTK/ERK signaling dynamics in BRAF-mutant melanoma. Congratulations to Sungsoo Kim (2023).
  • Yang lab awarded the Research Scholar Grant (RSG) from American Cancer Society (2023).
    https://pressroom.cancer.org/ResearchGrants2022
    https://www.cancer.org/research/we-fund-cancer-research/apply-research-g...
  • Sungsoo received Scholar-in-Training Award from AACR (2023).
  • Yang lab awarded Career Development Award from the Melanoma Research Foundation (2022).
  • Yang lab awarded Center for Precision Cancer Medicine Pilot Grant (2022).
  • Yang lab awarded Velocity Award (2021).
  • Yang lab awarded a pilot grant for developing a high-throughput screening platform for COVID-19 drugs (2020).